Replies to post #300654 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

Don't forget about the Open Label Extension

Subjects from the OLE cannot hide the benefits. Their doctors know, the patients themselves know, their spouses know, their families know, their friends know.

Over 250 subjects out of the total of 450 anticipated subjects have completed at least 48 weeks of treatment and subsequently entered the OLE (Open Label Extension) trial when they all get Anavex 2-73 each and every day even if they were previously only getting a placebo.

In January 2020:

The trial has recruited around 250 of its 450 target since it commenced, Professor Macfarlane said.

https://www.australianageingagenda.com.au/executive/alzheimers-drug-trial-shows-promise/

Good luck and GOD bless,